JBJoanna W. A. M. Bosmans

Joanna W. A. M. Bosmans

*This is an algorithmically generated author record based on publicly available information.

Joanna W. A. M. Bosmans has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Management of soft tissue sarcomas of the chest wall: a comprehensive overview

    by Lori M. van Roozendaal, Joanna W. A. M. Bosmans, Jean H. T. Daemen, Aimee J. P. M. Franssen, James van Bastelaar, Sanne M. E. Engelen, Kristien B. M. I. Keymeulen, Wolfgang W. Schmidt Aguiar, Jose Ribas Milanez de Campos, Karel W. E. Hulsewé, et al.

    Sarcomas of the chest wall are rare and their current treatment regimen is diverse and complex due to the heterogeneity of these tumors as well as the variations in tumor location and extent. They only account for 0.04% of newly diagnosed cancers of whom about 45% comprise soft tissue sarcomas. Larger cohort studies are scarce and often focus on one specific treatment item. We therefore aim to provide helicopter view for clinicians treating patients with sarcomas of the chest wall, focusing mainly on soft tissue sarcomas. This overview includes the value of neoadjuvant systemic or radiotherapy, surgical resection, approaches for thoracic wall reconstruction, and the need for follow-up. Provided the heterogeneity and relative rarity, we recommend that treatment decisions in soft tissue sarcoma of the chest wall are discussed in a multidisciplinary tumor board at a reference sarcoma center or within sarcoma networks to ensure personalized, rational decision making. A surgical oncologist specialized in sarcoma surgery is crucial, and for extensive resections involving the thoracic cavity we recommend involvement of a thoracic surgeon. In addition, a specialized medical- and radiation oncologist as well as a plastic surgeon is required to ensure the best multimodality treatment plan to optimize patient outcome.


  • Open Access

    Enhanced bioadhesivity of dopamine-functionalized polysaccharidic membranes for general surgery applications

    by F. Scognamiglio, A. Travan, M. Borgogna, I. Donati, E. Marsich, J.W.A.M. Bosmans, L. Perge, M.P. Foulc, N.D. Bouvy, S. Paoletti


  • Open Access

    Predictive Factors for Anastomotic Leakage After Colorectal Surgery: Study Protocol for a Prospective Observational Study (REVEAL Study)

    by Audrey Chm Jongen, Joanna Wam Bosmans, Serdar Kartal, Tim Lubbers, Meindert Sosef, Gerrit D Slooter, Jan H Stoot, Frederik-Jan van Schooten, Nicole D Bouvy, Joep Pm Derikx

    Anastomotic leakage (AL) remains the most important complication following colorectal surgery, and is associated with high morbidity and mortality rates. Previous research has focused on identifying risk factors and potential biomarkers for AL, but the sensitivity of these tests remains poor. This prospective multicenter observational study aims at combining multiple parameters to establish a diagnostic algorithm for colorectal AL. This study aims to include 588 patients undergoing surgery for colorectal carcinoma. Patients will be eligible for inclusion when surgery includes the construction of a colorectal anastomosis. Patient characteristics will be collected upon consented inclusion, and buccal swabs, breath, stool, and blood samples will be obtained prior to surgery. These samples will allow for the collection of information regarding patients' inflammatory status, genetic predisposition, and intestinal microbiota. Additionally, breath and blood samples will be taken postoperatively and patients will be strictly observed during their in-hospital stay, and the period shortly thereafter. This study has been open for inclusion since August 2015. An estimated 8-10% of patients will develop AL following surgery, and they will be compared to non-leakage patients. The objectives of this study are twofold. The primary aim is to establish and validate a diagnostic algorithm for the pre-operative prediction of the risk of AL development using a combination of inflammatory, immune-related, and genetic parameters. Previously established risk factors and novel parameters will be incorporated into this algorithm, which will aid in the recognition of patients who are at risk for AL. Based on these results, recommendations can be made regarding the construction of an anastomosis or deviating stoma, and possible preventive strategies. Furthermore, we aim to develop a new algorithm for the post-operative diagnosis of AL at an earlier stage, which will positively reflect on short-term survival rates. Clinicaltrials.gov: NCT02347735; https://clinicaltrials.gov/ct2/show/NCT02347735 (archived by WebCite at http://www.webcitation.org/6hm6rxCsA).